CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2025	Sep. 30, 2024
Cash flows from operating activities:
Net income (loss)	$ 357,440	$ (55,118)
Adjustments to net income (loss):
Depreciation and amortization	490,046	477,060
Deferred income tax expense (benefit)	103,566	10,776
Impairments and other charges	31,102	15,379
Amortization of debt discount and deferred financing costs	6,681	6,757
Bargain purchase gain	(116,499)
Losses (gains) on debt buyback	1,948	14,857
Losses (gains) on sale of long-lived assets, net	(13,362)	17,109
Share-based compensation	14,623	11,825
Foreign currency transaction losses (gains), net	5,347	21,317
Mark-to-market (gain) loss on warrants	(7,424)	(12,538)
Gain on disposition of Quail Tools	(415,557)
Other	3,974	5,445
Changes in operating assets and liabilities, net of effects from acquisitions:
Accounts receivable	(15,813)	(38,163)
Inventory	19,904	4,337
Other current assets	(22,651)	(6,900)
Other long-term assets	15,596	(1,311)
Trade accounts payable and accrued liabilities	(4,553)	583
Income taxes payable	1,980	(24,912)
Other long-term liabilities	(8,923)	(13,990)
Net cash provided by (used for) operating activities	447,425	432,513
Cash flows from investing activities:
Purchases of investments	(4,336)	(7,681)
Cash acquired in stock based business combination, net of cash paid	84,429
Proceeds from disposition of Quail Tools	371,319
Capital expenditures	(553,886)	(359,873)
Proceeds from sales of assets	50,609	9,667
Other	7,502	4,671
Net cash (used for) provided by investing activities	(44,363)	(353,216)
Cash flows from financing activities:
Proceeds from issuance of long-term debt		550,000
Reduction in debt	(343,036)	(1,197,024)
Debt issuance costs		(11,045)
Proceeds from revolving credit facilities	398,000	225,000
Reduction in revolving credit facilities	(398,000)	(225,000)
Payment of dividend to former Parker shareholders	(6,052)
Payments for employee taxes on net settlement of equity awards	(2,151)	(2,634)
Dividends to common and preferred shareholders		(87)
Distributions to noncontrolling interest	(1,625)	(950)
Special purpose acquisition company redemptions by non-controlling redeemable shareholders	(186,655)
Other		(282)
Net cash (used for) provided by financing activities	(539,519)	(662,022)
Effect of exchange rate changes on cash and cash equivalents	(2,669)	(10,446)
Net increase (decrease) in cash and cash equivalents and restricted cash	(139,126)	(593,171)
Cash and cash equivalents and restricted cash, beginning of period	722,960	1,374,182
Cash and cash equivalents and restricted cash, end of period	583,834	781,011
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
Cash and cash equivalents, beginning of period	389,652	1,057,487
Restricted cash, beginning of period	333,308	316,695
Cash and cash equivalents and restricted cash, beginning of period	722,960	1,374,182
Cash and cash equivalents, end of period	428,051	451,649
Restricted cash, end of period	$ 155,783	$ 329,362
Restricted cash, Balance Sheet location	Restricted cash held in trust	Restricted cash held in trust
Cash and cash equivalents and restricted cash, end of period	$ 583,834	$ 781,011